tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Kevin Degeeter, 125 are a BUY (94.7%), 7 are a HOLD (5.3%).
Analyst Kevin Degeeter, currently employed at LADENBURG, carries an average stock price target met ratio of 41.86% that have a potential upside of 51.12% achieved within 315 days. Previously, Kevin Degeeter worked at OPPENHEIMER.
Kevin Degeeter’s has documented 258 price targets and ratings displayed on 40 stocks. The coverage is on Healthcare, Industrials sectors.
Most recent stock forecast was given on CLRB, Cellectar Biosciences at 15-May-2026.
Analyst best performing recommendations are on DMTK (DERMTECH).
The best stock recommendation documented was for FLGT (FULGENT GENETICS) at 2/1/2021. The price target of $130 was fulfilled within 1 day with a profit of $7.91 (5.74%) receiving and performance score of 57.36.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 09-Apr-2025
$6
$4.86 (426.32%)
$7
6 months 8 days ago
(13-Apr-2026)
0/4 (0%)
$4.87 (430.97%)
Hold Since 25-Jan-2024
$8
$6.75 (540.00%)
$8
7 months 1 days ago
(20-Mar-2026)
1/5 (20%)
$6.85 (595.65%)
523
Hold Since 02-Apr-2025
$4
$2.75 (220.00%)
$60
1 years 6 months 19 days ago
(02-Apr-2025)
1/7 (14.29%)
$0.25 (6.67%)
8
Hold Since 18-Nov-2024
1 years 11 months 3 days ago
(18-Nov-2024)
0/8 (0%)
$94.8 (376.19%)
Buy Since 26-Jan-2021
$5.4
1 years 11 months 6 days ago
(15-Nov-2024)
2/5 (40%)
$-18.6 (-77.50%)
97
Which stock is Kevin Degeeter most bullish on?
What Year was the first public recommendation made by Kevin Degeeter?
